Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
4.770
+0.940 (24.54%)
At close: Mar 27, 2026, 4:00 PM EDT
5.05
+0.28 (5.87%)
After-hours: Mar 27, 2026, 7:59 PM EDT
Quantum BioPharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
17
Market Cap
27.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Neuphoria Therapeutics | 14.99M |
| Barinthus Biotherapeutics | 14.97M |
| Curis | 9.44M |
| Marker Therapeutics | 3.55M |
| Longeveron | 1.20M |
| XTL Biopharmaceuticals | 968.00K |
| Daré Bioscience | -57.13K |
QNTM News
- 47 minutes ago - Quantum Biopharma Provides Corporate Update - GlobeNewsWire
- 12 hours ago - Quantum Biopharma's 2025 Audited Year End Financial Results Maintain ‘No Going Concern' Status - GlobeNewsWire
- 4 days ago - Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd - GlobeNewsWire
- 7 days ago - Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering - GlobeNewsWire
- 16 days ago - Quantum BioPharma Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM - PRNewsWire
- 5 weeks ago - Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewsWire
- 5 weeks ago - Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma, Ltd. Investors - GlobeNewsWire